Leading life insurance companies are embracing innovation to detect cancer early
A new era of cancer screening is here with the Galleri® test
The Galleri test can be taken annually as a simple blood test and screens for a "fingerprint" of many of the deadliest cancers before they become symptomatic, including those with no recommended screening tests today.1,2,3
The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur.
Learn how Dave, Founder & CEO of OneTeam Financial, was able to offer his longtime friend and client the Galleri test.
Hear why our life insurance partners are embracing innovation
to detect cancer early
-
Munich Re and John Hancock
-
M Financial Group
-
GRAIL + John Hancock Vitality
Galleri for Policyholders
There are over 100 types of cancer, but only 5 have recommended screening tests.2,3
Your clients deserve more.
The benefits of adding multi-cancer early detection
Do more to screen for cancer
Screen for many of the deadliest cancers, including cancers without recommended screening tests.1
Test with ease
Completed with a simple blood draw.
Actionable results
If a cancer signal is found, the results provide prediction for the cancer signal origin to help guide next steps for diagnosis.
The Galleri test is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.
Galleri should be used in addition to healthcare provider recommended screening tests.
Bring Galleri to your clients today. We're here to help.
Learn how screening with Galleri has made a difference for these patients
-
Patient testimonial: Kevin
Cancer Signal Detected
-
Patient testimonial: Kara
Cancer Signal Detected
-
Patient testimonial: Jackie
Cancer Signal Detected
-
Patient testimonial: Gracie
Cancer Signal Detected
-
Patient testimonial: Neil
Cancer Signal Detected
-
Patient testimonial: Mike
Cancer Signal Detected
-
Patient testimonial: Rich & Staci
Cancer Signal Detected
-
Patient testimonial: Cindy
Cancer Signal Detected
-
Patient testimonial: Dave
Cancer Signal Detected
-
Patient testimonial: Jennifer
No Cancer Signal Detected
-
Patient testimonial: Jonathan
Cancer Signal Detected
-
Patient testimonial: Rich
Cancer Signal Detected
-
Patient testimonial: Cindy
Cancer Signal Detected
-
Patient testimonial: Mary and her doctor, Robert Korolevich, MD
Cancer Signal Detected
-
Patient testimonial: Roger
Cancer Signal Detected
-
Patient testimonial: Valerie
Cancer Signal Detected
-
Patient testimonial: Keith
No Cancer Signal Detected
-
Patient testimonial: Tami
No Cancer Signal Detected
Meet the GRAIL Life Insurance Advisory Committee
We’ve partnered with forward-thinking industry leaders to help get one million Galleri tests into the hands of policyholders through their life insurance companies.
Learn more about the committee
Galleri and life insurance leaders are making headlines
Ready to Get Started?
Fill out this form to bring Galleri to your clients today.
By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.
Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.
If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.
The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed — and its performance characteristics were determined — by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.
- Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167-77. DOI:https://doi.org/10.1016/j.annonc.2021.05.806.
- National Cancer Institute. What Is Cancer? https://www.cancer.gov/about-cancer/understanding/what-is-cancer.
- US Preventive Services Task Force Recommended Screenings. https://www.uspreventiveservicestaskforce.org/uspstf/topic_search_results.